Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2023 Feb 4;13:2028. doi: 10.1038/s41598-023-29011-2

Haematological indices and immune response profiles in dogs naturally infected and co-infected with Dirofilaria repens and Babesia canis

Dagmara Wężyk 1,#, Karolina Romanczuk 2,#, Anna Rodo 3,4, Dziyana Kavalevich 1, Anna Bajer 1,
PMCID: PMC9899214  PMID: 36739305

Abstract

Co-infections with Dirofilaria repens and Babesia canis are rarely reported in the literature and there is very limited knowledge of their impact on canine health. Central Poland is endemic for both parasites, posing a risk of co-infections in dogs. To evaluate the impact of co-infection with B. canis and D. repens on canine health, four groups of dogs were examined: healthy dogs, dogs infected with B. canis, dogs infected with D. repens and dogs co-infected with both species. Blood parameters indicative of anaemia, kidney and liver damage were analysed statistically. Additionally, expression levels of immune response genes were quantified and compared, to define the type of immune response typically encountered in single- and co-infections. In dogs infected with D. repens, no major alterations in blood parameters were observed. Dogs infected with B. canis suffered from anaemia, kidney and liver insufficiency. In contrast, dogs co-infected with D. repens and B. canis showed milder alternation in blood biochemical parameters associated with liver (ALP activity) and kidney (serum urea and creatinine levels) dysfunction, compared to dogs infected only with B. canis. The expression of genes associated with cellular (Th1-mediated) (STAT4 and INF-γ), humoral (Th2-mediated) (STAT6, GATA3, SOCS3, IL-13) and regulatory (IL-10) responses was quantified. For this analysis, dogs infected with B. canis were divided into two groups—‘Babesia 1’ (mild babesiosis), ‘Babesia 2’ (severe babesiosis). All the tested factors, except INF-γ, were found to be expressed in dogs infected with D. repens. In ‘Babesia 1’ dogs, expression of GATA3 was highest, while in ‘Babesia 2’—INF-γ and SOCS3 dominated. IL-13 expression was predominant in dogs infected with D. repens, and STAT6 and IL-10 predominated in dogs with co-infections.

Subject terms: Immunology, Molecular biology, Zoology

Introduction

Babesia canis and Dirofilaria repens are widespread parasites of dogs, with expanding geographical distribution in Central and North-Eastern Europe19. Babesiosis due to B. canis infection is an emerging tick-borne disease1,2,10,11. The most common symptoms of babesiosis are lethargy, fever, anorexia, icterus and exercise intolerance1113. While some infected dogs remain asymptomatic or present with only mild transient symptoms1,11,14, the outcome of infection can be fatal in dogs with severe babesiosis, and despite treatment, fatality ranges 2–10%1,2. Some dogs may develop shock and/or renal failure leading to death12,1518. Following the acute phase of infection, piroplasm infections may persist in a host in chronic form1921.

The diverse course and outcomes of B. canis infections have led to the assumption that it is not the impact of the parasite itself (causing direct cell damages and local inflammatory process) but rather the secondary immunopathology (e.g. the induction of autoantibodies or formation and deposition of immune complexes of antigen, antibody and complement) that is responsible for the major pathological consequences of infection17,22. The host immune response to Babesia spp. is not well recognized due to a range of factors influencing the response, including different phases of infection (colonization, acute phase, resolution and/or transition to chronic phase), different course/outcome of infection, possible co-infections and individual differences observed in experimental infections in dogs2224. As intraerythrocytic parasites, babesia are believed to induce a protective Th1-regulated cellular immune response with interferon gamma (IFN-γ) playing a key role in clearance of parasites from the blood17,22,25,26. However, host immunity in vector-borne canine diseases is often dominated by Th2-regulated humoral responses rather than the Th1-regulated cellular arm of the immune system22. This allows persistence of infection and facilitates the development of the inappropriate secondary immunopathology referred to above, characterised by hypergammaglobulinemia, autoantibody and immune complex formation, contributing to further pathologies17. Therefore, in dogs infected with B. canis, we might expect different levels of expression of a wide range of cytokines and transcription factors, from the pro-inflammatory cytokine IFN-γ, tumour necrosis factor (TNF-α), interleukin (IL-2), the immunosuppressive IL-10, to cytokines associated with Th2 immune responses (i.e. IL-4, IL-5, IL-10 and IL-13)17. Moreover, we might expect more complex expression of immune factors in dogs with a range of babesiosis symptoms than in asymptomatic infected dogs, as has been found in dogs diagnosed with leishmaniasis22.

In the case of D. repens, long-term asymptomatic infection may occur in dogs, and the reported symptoms are usually mild4,2729. The vectors of D. repens are mosquitoes of the family Culicidae3032. The mosquito, by feeding on the blood of an infected individual, uptakes the L1 stage larvae (microfilariae), which move into the mosquito's gut within 1–3 days. From there, they migrate to the Malpighian tubules, where they moult twice to develop into L3 stage larvae. L3 migrate to the mosquito's mouth organs and during next blood uptake are inoculated into the dermis of the definitive host where, after several months of migration, they settle under the skin (in subcutaneous or connective tissues), mature and reproduce6,8. Females release microfilariae, which circulate in canine blood33,34. The presence of adult nematodes may be associated with the formation of subcutaneous nodules, but apparently may also not cause a local inflammatory process. Some dogs remain microfilaraemic for a long period (patent infection) but some may be amicrofilaraemic (occult infections)35. MFs were also found in the parenchyma and/or blood vessels in numerous vital organs of dogs and their presence was associated with necrotic foci and infiltration of inflammatory cells (particularly eosinophils) in the liver, kidneys and the heart36. Over the course of several years of infection (2–5 years)29,37 D. repens females produce new generations of microfilariae (MF) and their concentration in the blood may achieve high levels38. The co-occurrence of Babesia and MF in circulating blood might contribute to pronounced changes in blood indices of co-infected dogs. Studies on pathology caused by D. repens in dogs are scarce36,39, as is knowledge on induced immune responses. Much more is known about immune response to more pathogenic Dirofilaria immitis, causing pulmonary dirofilariasis35,40,41.

In contrast to viruses, bacteria or protists, helminths usually cause long-lasting infections and promote Th2-regulated immune responses4245. This is possible due to their immunomodulatory effects on hosts, the main strategy for their survival43. Filariae cause long-lasting chronic infections in humans and animals via the production of a range of immunomodulatory molecules affecting host responses45,46. Interestingly, alternation of immune response types has been observed in numerous previous studies of co-infections with protists and helminths, which have provided evidence for either deepened or mitigated pathology in such co-infections46,47. Thus, a highly relevant question is how this modulation influences the host in terms of reduced or increased immune pathology and host survival45.

Our aim was to determine the effect of co-infection with D. repens and B. canis on canine health. Our studies on dogs in central Poland in 2015 revealed a very high rate of co-infections with B. canis and D. repens in dogs treated for babesiosis and lack of asymptomatic co-infections in healthy dogs48. Contrary to our predictions, the values of biochemical parameters in dogs with co-infections were closer to those of healthy dogs than those solely infected with B. canis, suggesting milder babesiosis in these animals48. These findings are important due to the current spread of dirofilariosis in central Europe, which being mostly undiagnosed has resulted in large numbers of untreated microfilaremic dogs in the region that may be more prone to babesiosis. The possible protective effect of the nematode infection on hepatic or renal dysfunction in canine babesiosis is intriguing and its mechanisms require further investigation.

We expected D. repens mainly to activate Th2-regulated immune responses as in other filarial nematodes and patent D. immitis infections35,42,46. Therefore, in the current study we tested this hypothesis, predicting that infection with filariae would drive the host response towards Th2-type immunity. This in turn should result in a reduction of proinflammatory Th1-type responses that are crucial for the elimination of intracellular pathogens, including protozoa such as B. canis.

Methods

Material

A total of 140 EDTA-fixed blood samples were obtained in 2018–2020 through cooperation with veterinary practitioners and the veterinary diagnostic laboratory Lab-Wet. Samples were collected in Masovia, Central Poland, the region that is endemic for both D. repens and B. canis4,29,48. Criteria for inclusion of samples in the study were: (1) samples collected from clinically healthy dogs, older than 1 year; (2) samples collected from dogs with symptoms of babesiosis with laboratory confirmed B. canis infection.

Inclusion criteria were not based on D. repens infection status, thus all obtained samples were examined for Dirofilaria infection by molecular methods, PCR amplification and sequencing of two genetic markers, a 320 bp fragment of 12S rDNA48 and an approximately 600 bp-long fragment of the NADH gene4. To confirm B. canis infection in dogs with babesiosis symptoms and to detect any asymptomatic infections, all samples were also tested for B. canis by PCR amplification and sequencing of two markers, a 550 bp fragment of 18S rDNA49 and a 330 bp fragment of the mitochondrial cytochrome c oxidase subunit 1 (cox1)50. On this basis, dogs were allocated to four groups: control healthy dogs (n = 39), dogs infected with B. canis (n = 82), dogs infected with D. repens (n = 12) and dogs co-infected with B. canis and D. repens (n = 7). Complete results of haematological investigations (a range of haematological indices, including blood counts, biochemistry, etc.; (Table 1) were provided for these 140 dogs by two diagnostic laboratories (Lab-Wet, VetLab). A subset of 54 samples (three healthy control dogs, 32 selected dogs with babesiosis, 12 dogs infected with D. repens and seven dogs co-infected with B. canis and D. repens) were involved in the study on the expression levels of selected cytokines/transcription factors. Due to financial limits, it was not possible to examine expression in all Babesia-positive dogs, thus dogs representing mild and severe disease were chosen randomly.

Table 1.

Comparison of blood parameters between healthy dogs, infected with one parasite, and dogs with co-infection.

Parameter Mean parameter value ± SEM Reference values The value of the F statistic P
Healthy dogs (N = 39) Dogs with B. canis (N = 82) Dogs with D. repens (N = 12) Dogs with co-infection (N = 7)
Morphological indices
 Erythrocytes (T/l) 7.06 ± 0.210 5.05 ± 0.145a 6.16 ± 0.379 5.77 ± 0.496 5.50–8.50 F3, 139 = 22.64  < 0.001
 Leukocytes (G/l) 9.56 ± 0.788 5.32 ± 0.543a 9.53 ± 1.420 5.32 ± 1.859a 6.0–12.0 F3, 139 = 9.23  < 0.001
 Hemoglobin (mmol/l) 10.54 ± 0.229 7.49 ± 0.206a 8.18 ± 0.539a 8.61 ± 0.706a 9.30–11.8 F3, 139 = 26.22  < 0.001
 Hematocrit (%) 46.55 ± 2.823 22.48 ± 1.947a 37.65 ± 5.089a 36.14 ± 6.664a 44.0–55.0 F3, 139 = 17.29  < 0.001
 MCV (fl) 70.09 ± 1.050 69.86 ± 0.724 69.13 ± 1.892 71.31 ± 2.477 60.0–77.0 F3, 139 = 0.191 0.920
 MCH (pg) 23.02 ± 1.677 16.62 ± 1.157a 19.53 ± 3.024 21.16 ± 3.959 19.0–24.0 F3, 139 = 6.19  < 0.001
 MCHC (g/dl) 33.41 ± 1.231 29.95 ± 0.849 31.36 ± 2.219a 32.20 ± 2.905 32.0–36.0 F3, 139 = 6.00 0.002
 Thrombocytes (g/l) 228.64 ± 17.945 27.59 ± 12.375a 206.75 ± 32.35 31.57 ± 42.356a 150.0–500.0 F3, 139 = 55.83  < 0.001
Biochemical indices
 Serum glucose (mg/dl) 61.48 ± 7.095 78.67 ± 5.117 51.38 ± 13.36a 74.66 ± 16.748 54.9–109.8 F3, 129 = 1.47 0.192
 Creatinine (mg/dl) 1.00 ± 0.162 1.14 ± 0.115 0.92 ± 0.306 1.01 ± 0.383 0.396–1.49 F3, 132 = 0.26 0.935
 Serum urea (mg/dl) 31.85 ± 12.010 76.61 ± 8.548b 40.08 ± 22.615 77.08 ± 28.349b 19.9–50.0 F3, 132 = 2.38 0.041
 Total serum protein (g/l) 66.32 ± 1.202 54.81 ± 0.855 69.00 ± 2.263 60.18 ± 2.837 54.0–75.0 F3, 98 = 16.5  < 0.001
 AST (U/l) 36.31 ± 15.233 101.87 ± 10.98b 41.14 ± 28.68 80.90 ± 35.955b 1.0–76.0 F3, 130 = 2.82 0.018
 ALT (U/l) 37.68 ± 11.391 67.92 ± 8.160 40.06 ± 21.44 116.63 ± 26.88b 1.0–80.0 F3, 131 = 2.70 0.023
 ALP (U/l) 53.39 ± 12.311 154.05 ± 8.762b 81.52 ± 23.18 85.09 ± 29.059 1.0–141.0 F3, 130 = 11.30  < 0.001

aDecreased blood parameters.

bIncreased blood parameters.

RNA extraction, reverse transcription and qPCR

400 μl of EDTA- fixed whole blood samples were centrifuged for 10 min at a temperature of 4 °C to remove red blood cells. The supernatant was harvested and then total RNA was isolated using the mirVana™ miRNA Isolation Kit (Thermo Fisher Scientific, Waltham, Massachusetts, U.S.) according to the manufacturer’s instructions. RNA was quantified using Nanodrop One (Thermo Fisher Scientific). Reverse transcription was conducted to obtain cDNA for qPCR analysis, using at least 100 μg of total RNA. cDNA was synthesized using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, Massachusetts, U.S.) according to the manufacturer’s instructions. The quantitative polymerase chain reaction (qPCR) assays were performed using TaqMan Gene Expression Master Mix (Thermo Fisher Scientific, Waltham, Massachusetts, U.S.) and the following TaqMan probes: Cf02623316_m1 (IFN-γ), Cf02624080_m1 (IL-13), Cf02624265_m1 (IL-10), Cf02741636_m1 (GATA3), Cf02676700_m1 (STAT4), Cf01127458_m1 (STAT6), Cf02690456_g1 (hypoxanthine–guanine phosphoribosyl transferase, HPRT). HPRT expression was used as an endogenous reference gene. Data were normalized to the expression observed in a group of three healthy dogs, whose blood parameters were within the normal range. Gene expression analysis was performed in duplicates. All qPCR reactions were performed on a LightCycler96 instrument (Roche, Basel, Switzerland). The amplification curves were analysed using LightCycler 96 software (Roche) to determine the Ct values. According to the Livak and Schmittgen method, the relative quantification was calculated using 2−ΔΔCt analysis51. Results are presented as means and standard errors of the mean (SEM).

Statistical analysis

Statistical analyses for morphological and biochemical blood indices were performed using IBM SPSS v. 26 software. General Linear Models (GLM) were implemented with morphological and biochemical blood parameters as dependent variables and infection status in dogs as the explanatory factor (four levels corresponding to four groups of dogs: healthy dogs, dogs with B. canis infection, dogs with D. repens infections, dogs with co-infection of B. canis and D. repens).

In a further stage of analysis, severity of symptoms of babesiosis (the magnitude of changes in haematological and biochemical indices) was included as an explanatory factor in GLMs. For this analysis the dogs were allocated to three classes of severity of babesiosis (described below) and statistical analysis (GLM) was performed to confirm correct categorization of scores (Table 2). The presence/absence of D. repens infection, was fitted as a binary factor (infected = 1, not infected = 0) in further GLMs, incorporating also severity scores of babesiosis (1–3) as dependent variables (anaemia, hepatic or renal dysfunction, see below). Classification of severity was based on the criteria provided in Bajer et al. (2016)48. The three main groups of general symptoms (indicators of mortality in canine babesiosis) included: a. severity of anaemia (severity score 0—RBC counts within normal range 5.5–8.0 T/l; severity score 1—RBC counts in a range 4.5–5.5 T/l; severity score 2—RBC below 4.5 T/l); b. hepatic dysfunction parameters (measures of enzymes activity) based on reference values for AST– aspartate aminotransferase, ALT- alanine aminotransferase and ALP- alkaline phosphatase within, above (up to 100 U/l) and profoundly above (> 100 U/l) the normal range, representing scores of 0, 1 and 2, respectively (Table 2); c. renal dysfunction parameters (based on reference values for serum urea) within, above (up to 100 mg/dl) and profoundly above (> 100 mg/dl) the normal range, representing severity scores of 0, 1 and 2, respectively (Table 2).

Table 2.

Comparison of selected blood parameters in classifying the severity of the main symptoms in canine babesiosis.

Symptoms and associated blood parameters ± SEM Severity class Reference values Value of statistics F P
Class 0 (normal) Class 1 (mild) Class 2 (advanced disorder)
Anemia N = 101 N = 38 N = 31
Erythrocytes (T/l) 6.75 ± 0.79 5.06 ± 0.129 3.39 ± 0.142 5.50–8.50 F2, 169 = 231.75  < 0.001
Leukocytes (G/l) 8.09 ± 0.562 7.17 ± 0.917 8.12 ± 1.015 6.0–12.0 F2, 169 = 0.40 0.673
Hemoglobin (mmol/l) 9.96 ± -0.122 7.56 ± 0.199 5.21 ± 0.220 9.30–11.8 F2, 169 = 194.04  < 0.001
Hematocrit (%) 39.51 ± 1.778 26.48 ± 2.899 15.90 ± 3.210 44.0–55.0 F2, 169 = 23.28  < 0.001
Thrombocytes (g/l) 164.40 ± 14.680 151.23 ± 23.932 28.10 ± 26.497 150.0–500.0 F2, 169 = 10.36  < 0.001
Hepatic dysfunction N = 80 N = 48 N = 33
AST (U/l) 42.50 ± 10.146 82.53 ± 13.099 140.56 ± 15.798 1.0–76.0 F2, 160 = 13.90  < 0.001
ALT (U/l) 38.10 ± 7.330 65.49 ± 9.366 124.46 ± 11.413 1.0–80.0 F2, 161 = 20.28  < 0.001
ALP (U/l) 68.89 ± 6.229 124.67 ± 8.049 249.81 ± 9.960 1.0–141.0 F2, 160 = 117.93  < 0.001
Renal dysfunction N = 106 N = 33 N = 24
Creatinine (mg/dl) 0.899 ± 0.093 1.003 ± 0.167 1.795 ± 0.195 0.396–1.49 F2, 162 = 8.62  < 0.001
Serum urea (mg/dl) 31.69 ± 5.180 70.06 ± 9.284 190.40 ± 10.887 19.9–50.0 F2, 162 = 87.02  < 0.001

For the next step of analysis, 82 dogs infected with B. canis were divided into three classes of severity of babesiosis (Table 3). All dogs with any of these three general pathologies classified as ‘severity score 2’ were assigned to group 3 (severe babesiosis, severity level 3, n = 44). Dogs presenting with more than one dysfunction (anaemia, signs of hepatic or renal failure) at level 1 (abnormal) were assigned to group 2 (moderate babesiosis, severity level 2, n = 16) and dogs presenting with one group of signs (mainly mild anaemia and thrombocytopenia) were assigned to group 1 (mild babesiosis, severity level 1, n = 22).

Table 3.

Comparison of blood parameters between healthy dogs, infected with one parasite, and dogs with co-infection in different classes of symptom severity.

Level Mean blood parameters ± SEM Reference values Healthy dogs (N = 39) Dogs with B. canis (N = 82) Dogs with D. repens (N = 12) Dogs with coinfection (N = 7) Value of statistics F P
Anemia
 Level 0 Erythrocytes (T/l) 5.50–8.50 7.06 ± 0.12 6.28 ± 0.13 6.91 ± 0.26 6.59 ± 0.378

F10, 137 = 7.08

F10, 137 = 2.06

F10, 137 = 0.94

F10, 137 = 3.44

F10, 137 = 0.75

0.611

0.003

0.47

0.06

 < 0.001

Leukocytes (G/l) 6.0–12.0 9.56 ± 0.74 5.24 ± 0.80 10.89 ± 1.65 2.86 ± 2.337
Hemoglobin (mmol/l) 9.30–11.8 10.54 ± 0.18 9.14 ± 0.19 9.88 ± 0.40 9.48 ± 0.571
Hematocrit (%) 44.0–55.0 46.55 ± 2.63 25.59 ± 2.82 47.53 ± 5.82 44.06 ± 8.234
Thrombocytes (g/l) 150.0–500.0 228.64 ± 15.7 38.36 ± 16.87 219.62 ± 34.7 37.32 ± 49.18
 Level 1 Erythrocytes (T/l) 4.99 ± 0.15 5.15 ± 0.53 4.65 ± 0.53
Leukocytes (G/l) 4.38 ± 0.95 8.96 ± 3.30 4.30 ± 3.30
Hemoglobin (mmol/l) 7.49 ± 0.23 7.44 ± 0.80 6.60 ± 0.80
Hematocrit (%) 24.36 ± 3.36 35.55 ± 11.64 0.33 ± 0.67
Thrombocytes (g/l) 16.77 ± 20.08 329.5 ± 69.56 39.0 ± 59.56
 Level 2 Erythrocytes (T/l) 3.36 ± 0.15 4.14 ± 0.53 4.01 ± 0.75
Leukocytes (G/l) 6.38 ± 0.95 4.65 ± 3.30 4.66 ± 4.67
Hemoglobin (mmol/l) 5.16 ± 0.23 5.95 ± 0.80 5.98 ± 1.14
Hematocrit (%) 16.21 ± 3.36 29.0 ± 11.6 9.96 ± 11.44
Thrombocytes (g/l) 23.12 ± 20.08 32.50 ± 69.56 23.01 ± 28.37
Hepatic dysfunction
 Level 0 AST (U/l) 1.0–76.0 36.32 ± 5.76 52.16 ± 7.50 41.87 ± 12.00 51.45 ± 25.45

F10, 127 = 2.94

F10, 129 = 4.77

F10, 128 = 0.99

0.01

 < 0.001

0.429

ALT (U/l) 1.0–80.0 37.68 ± 9.77 37.81 ± 12.73 37.80 ± 20.35 43.30 ± 43.18
AP (U/l) 1.0–141.0 53.39 ± 8.29 98.58 ± 10.83 57.00 ± 17.27 65.00 ± 36.63
 Level 1 AST (U/l) 86.99 ± 6.26 43.90 ± 36.00 69.1 ± 18.00
ALT (U/l) 58.10 ± 10.47 61.60 ± 61.06 67.95 ± 30.53
AP (U/l) 129.92 ± 8.88 175.30 ± 51.8 86.15 ± 25.90
 Level 2 AST (U/l) 134.08 ± 8.48 31.70 ± 36.00 187.0 ± 36.00
ALT (U/l) 121.94 ± 14.0 38.90 ± 61.06 458.00 ± 61.06
AP (U/l) 258.82 ± 11.5 208.40 ± 51.8 121.00 ± 51.80
Renal dysfunction
 Level 0 Creatinine (mg/dl) 0.396–1.49 1.00 ± 0.16 0.88 ± 0.156 0.88 ± 0.35 1.03 ± 0.49

F10, 130 = 0.13

F10, 130 = 0.81

0.992

0.562

Serum urea (mg/dl) 19.9–50.0 30.84 ± 8.84 34.10 ± 8.619 28.29 ± 19.2 36.85 ± 27.25
 Level 1 Creatinine (mg/dl) 0.97 ± 0.98 1.04 ± 0.22 1.00 ± 0.57 1.20 ± 0.98
Serum urea (mg/dl) 69.95 ± 54.51 73.05 ± 12.18 71.53 ± 31.47 74.77 ± 54.51
 Level 2 Creatinine (mg/dl) 1.87 ± 0.24 1.24 ± 0.69
Serum urea (mg/dl) 180.80 ± 13.2 158.71 ± 38.55

Statistical analyses for comparison of gene expression levels were performed with GraphPad Prism 9.4.0. Shapiro–Wilk and Kruskal–Wallis tests were used to compare relative mean expression levels between the groups. The level of significance was set at P ≤ 0.05.

Ethics approval and consent to participate

The study was carried out on blood samples provided voluntarily by dog owners, thus no ethical approval/ license was required for this study (as per Resolution on the protection of animals used for scientific or educational purposes, 15th January 2015 [Dz. U. 2015 position 266] Chapter 1, Paragraph 1.2.1). The owners of dogs involved in this study were informed about the aims of the study, provided oral consent and contact information to obtain the results of testing. Haematological tests for these dogs were conducted as commercial service by VetLab diagnostics laboratory (Warsaw, Poland) and costs of testing were covered by the project. Additionally, blood remnants obtained after testing were provided by dr Anna Rodo from Lab-Wet diagnostic laboratory (Warsaw, Poland), co-author of the current paper, with the consent from the head of Lab-Wet unit in Warsaw.

Results

Prevalence of Dirofilaria repens

The DNA of D. repens was detected in 19 of 140 examined dogs giving an overall prevalence of 13.5% (combined dogs with single- and co-infections). Prevalence was 23.5% among 51 ‘healthy’ dogs and 7.8% among 89 dogs infected with B. canis.

Effect of parasite infection on haematological parameters

A range of haematological parameters was compared between four groups of dogs. The mean values of blood counts and biochemical parameters with relevant statistics are presented in Table 1.

The highest number of haematological abnormalities was observed in the group of dogs infected with B. canis: decreased mean number of erythrocytes, leukocytes, platelets, haemoglobin concentration, haematocrit, MCH, MCHC, and increased concentrations of serum urea and activity of the liver enzymes, AST and ALP (Table 1). Moreover, in this group of dogs mean values for erythrocytes, platelets, haemoglobin, haematocrit, MCH and MCHC were the lowest, and mean values for liver enzyme activity for ALP and AST the highest.

The lowest number of haematological alterations in comparison to the other groups was observed in the group of dogs infected only with D. repens: reduced mean concentrations of haemoglobin and glucose, decreased haematocrit and MCHC (Table 1). In dogs co-infected with B. canis and D. repens, alterations in seven blood indices were recorded: reduced mean numbers of leukocytes, platelets, concentration of haemoglobin, haematocrit value, and an increased concentration of serum urea and elevated activity of the liver enzymes AST and ALT (Table 1).

A classification of the severity of babesiosis symptoms for individual dogs was carried out to enable further analysis. The symptoms were compiled to create three general classes of symptoms (anaemia, symptoms of hepatic or renal failure), each with three severity levels (Table 2).

Statistical analysis of blood parameters confirmed the validity of classification based on all parameters except leukocyte counts (Table 2). A significant decrease in blood morphological parameters was observed in successive classes of severity of babesiosis based on severity of anaemia. In the case of renal and hepatic dysfunction, a more profound alteration of blood biochemical parameters was observed in successive classes of severity of babesiosis (Table 2).

In the next step, statistical comparisons of the haematological parameters were performed based on the classification of severity of different babesiosis symptoms (Table 3). Among the dogs with the most advanced anaemia (class 2), the greatest decrease in the mean RBC count and haemoglobin concentration was seen in dogs infected with B. canis, while the mean values of these indices were similar in dogs infected with D. repens and co-infected with B. canis and D. repens (Table 3). Among these groups of dogs with anaemia class 2, the lowest haematocrit and platelet count values were observed in dogs co-infected with B. canis and D. repens (Table 3).

In dogs with the most advanced alternations in enzyme activities (class 2), the pattern was diverse (Table 3). Dogs infected with B. canis presented with increased levels of activity of all three enzymes compared to normal values, and with the highest mean for ALP activity compared to other groups of infected dogs. Dogs co-infected with B. canis and D. repens presented with the highest mean ALT activity and elevated AST activity, and finally dogs infected with D. repens presented with only elevated ALP activity (Table 3).

No D. repens-infected dogs could be allocated to class 2 of renal disfunction based on serum urea concentration (Table 3). Among dogs with the most advanced renal dysfunction (class 2), B. canis-infected dogs presented with numerically higher mean serum creatinine and urea concentrations than dogs co-infected with B. canis and D. repens, although these differences were not statistically significant (Table 3).

Immune response in dogs infected with B. canis, D. repens and co-infected with B. canis and D. repens

To identify the immune response profile in dogs infected with one parasite or co-infected with both parasites, the expression level of genes of selected cytokines and transcription factors associated with Th1 or Th2-mediated response were determined as described previously. For this analysis, B. canis-infected dogs with mild and moderate babesiosis (representing classes 0 and 1) were combined into the group referred to as ‘Babesia 1’ and dogs with severe babesiosis (class 2) were assigned to ‘Babesia 2’.

Expression of cytokine genes and transcription factors related to cellular response (Th1-mediated)

INF-γ expression was detected in four groups (healthy dogs, dogs infected with B. canis [groups 1 and 2] and co-infected with B. canis and D. repens) (Fig. 1A). The expression of INF-γ was not detected in the group of dogs infected only with D. repens and expression was very low in dogs co-infected with B. canis and D. repens. The highest INF-γ expression was found in the group of dogs with severe babesiosis (Babesia 2) in contrast to the low expression level in dogs with mild/moderate babesiosis (Babesia 1). Significant differences in INF-γ gene expression were found between dogs infected with D. repens and dogs with severe babesiosis (Fig. 1A).

Figure 1.

Figure 1

Relative expression of genes associated with Th1 response. Expression of (A) INF-γ and (B) signal transducer and activator of transcription STAT4 in healthy dogs, dogs infected with B. canis, D. repens and co-infected with B. canis and D. repens (Bab + Diro).

STAT4 expression was found in four groups of dogs [dogs infected with B. canis (groups 1 and 2), dogs infected with D. repens and dogs co-infected with B. canis and D. repens] (Fig. 1B). STAT4 gene expression was not detected in healthy dogs. Among infected dogs, the lowest level of expression was found in dogs with severe babesiosis (Babesia 2), which presented with the highest INF-γ expression (Fig. 1A). However, the expression of STAT4 gene was generally similar in dogs with mild/moderate babesiosis (Babesia 1), infected with D. repens and co-infected with B. canis and D. repens (Bab + Diro) and differences in expression between groups were not statistically significant (Fig. 1B).

Expression of genes of cytokines and transcription factors associated with humoral response (Th2-mediated)

GATA3 gene expression was detected in four groups of dogs [dogs infected with B. canis (groups 1 and 2), dogs infected with D. repens and dogs co-infected with B. canis and D. repens] (Fig. 2A). No expression was detected in healthy dogs. The highest level of expression was found in dogs with mild/moderate babesiosis (Babesia 1) and the lowest in dogs with advanced babesiosis (Babesia 2). Low and similar level of GATA3 expression was found in dogs infected with D. repens and co-infected with B. canis and D. repens [not significant differences (NS); Fig. 2A].

Figure 2.

Figure 2

Relative expression of genes associated with Th2 and regulatory response. Expression of (A) transcription factor GATA3 (B) signal transducer and activator of transcription STAT6 (C) interleukin 13 (IL-13) and (D) suppressor of cytokine signalling (SOCS3) in healthy dogs, dogs infected with B. canis, D. repens and co-infected with B. canis and D. repens (Bab + Diro).

The expression of the STAT6 gene was observed in four groups of dogs [dogs infected with B. canis (groups 1 and 2), dogs infected with D. repens and dogs co-infected with B. canis and D. repens] (Fig. 2B). In healthy dogs, no STAT6 expression was detected. The highest level of expression was found in dogs co-infected with B. canis and D. repens and the lowest in dogs with mild/moderate babesiosis (Babesia 1). Low and similar level of STAT6 expression was found in dogs with advanced babesiosis (Babesia 2) and in dogs infected with D. repens. However, the differences in expression between groups were not statistically significant (Fig. 2B).

The expression of the IL-13 gene was detected in all groups, including healthy dogs (Fig. 2C). Although the differences in IL-13 gene expression between groups were not statistically significant, the highest level of expression (1.5 × higher than in healthy dogs), was found in dogs infected with D. repens (Fig. 2C).

Significant differences in the level of suppressor of cytokine signalling 3 gene (SOCS3) gene expression were found between the groups of dogs (Fig. 2D). The lowest level of expression was identified in healthy dogs and dogs co-infected with B. canis and D. repens. The highest level of SOCS3 expression was detected in dogs with severe babesiosis (Babesia 2), and was relatively high also in dogs with mild/moderate babesiosis and dogs infected only with D. repens (Fig. 2D).

Expression of the regulatory cytokine IL-10 gene

IL-10 gene expression was detected in four groups of dogs [dogs infected with B. canis (groups 1 and 2), dogs infected with D. repens and dogs co-infected with B. canis and D. repens] (Fig. 3). No IL-10 expression was detected in healthy dogs and expression level was very low in dogs with D. repens. The highest expression was found in dogs with co-infection. Relatively high and similar expression of IL-10 was found in dogs with mild/moderate and severe babesiosis (Fig. 3). Differences in the level of IL-10 gene expression between groups were not statistically significant (Fig. 3).

Figure 3.

Figure 3

Relative expression of interleukin 10 (IL-10) in healthy dogs infected with B. canis, D. repens, and co-infected with B. canis and D. repens (Bab + Diro).

Summary of immune response in dogs infected with B. canis, D. repens and co-infected with B. canis and D. repens

The expression of genes of all tested cytokines and related transcription factors (STAT4, INF-γ, GATA3, STAT6, IL-10, IL-13, SOCS3) was detected in three groups of dogs—in dogs with mild/moderate and severe babesiosis (groups Babesia 1 and Babesia 2) and in dogs co-infected with B. canis and D. repens (Figs. 1, 2, 3). The expression of all tested cytokines/factors except for INF-γ was observed in dogs infected only with D. repens.

Interestingly, there were profound differences in expression levels of cytokines/factors between dogs with mild/moderate and advanced babesiosis: the highest expression of STAT4, GATA3 and IL-10 was detected in group Babesia 1, while INF-γ, STAT6 and SOCS3 were expressed at a higher level in group Babesia 2.

Dogs infected with D. repens were characterized by slightly higher expression of IL-13 than dogs from other groups (Fig. 2C) and also relatively high expression of SOCS3 (Fig. 2D). Dogs co-infected with B. canis and D. repens were characterized by relatively high expression of STAT6 and IL-10 gene (Figs. 2B, 3).

Discussion

The main finding of our study is the clear demonstration of significant differences in blood indices and in the expression of immune factors in dogs with single and double infections. While only minor alterations in blood parameters were observed in dogs infected with D. repens, dogs with B. canis showed more severe pathology. However, contrary to our expectations, but in agreement with our previous study48, dogs with co-infections of D. repens and B. canis showed fewer abnormalities in blood counts and biochemical parameters associated with liver and kidney dysfunction compared to dogs infected only with B. canis. Analysis of expression levels of selected transcription factors/cytokines in these co-infected dogs provided evidence of activation of Th2-mediated and regulatory (IL-10) immune response.

While co-infected dogs showed fewer abnormalities in blood counts and biochemical parameters compared to dogs infected only with B. canis, the pathology they experienced was certainly more intense than that of dogs infected only with D. repens. In our previous study, co-infected dogs presented with more advanced anaemia (lowest mean RBC count, lowest haemoglobin concentration and lowest haematocrit) and thrombocytopenia than dogs infected only with B. canis, however they presented with lower alternations in biochemical parameters48. In the current study, the picture was slightly different because indices of anaemia were worse in dogs infected only with B. canis. Mean biochemical parameters were similar in co-infected dogs and dogs only with B. canis, with the exception of ALP activity (twice as high in dogs with B. canis) and ALT activity (more elevated in dogs with co-infection). Anaemia observed in dogs with babesiosis is considered to be one of the factors causing hypoxia and hypoxic liver injury, resulting in increases in ALT, AST and ALP activities52,53. Both ALT and AST are present in high concentrations in hepatocytes. Any damage to hepatocytes or their membranes can result in their leakage into the circulation54,55. Increase in the level of ALP may be due also to damage or abnormal function of the biliary system56.

In analyses based on allocation of dogs to severity classes, dogs co-infected with B. canis and D. repens presented with lower indices of renal dysfunction than dogs infected only with B. canis. In the class with the most advanced hepatic dysfunction, dogs infected with B. canis presented with much higher activity of ALP than dogs co-infected by B. canis and D. repens which is in agreement with previous observations52,57. However, co-infected dogs presented with the highest activity of ALT and AST, reflecting possible damages to hepatocytes52,54,55. Thus, in the present study co-infected dogs appear to have been more resistant to development of renal failure than dogs infected only with B. canis58, although they still showed some features of hepatic injury57.

As expected, the highest numbers of abnormalities/alternations in blood parameters were found in dogs with babesiosis. Similar alterations in blood parameters have been observed in numerous previous studies on babesiosis due to B. canis12,13,17,52,5860. The most common blood abnormalities occurring in the course of canine babesiosis, and also found in the present study, are thrombocytopenia, anaemia, leukopenia (although leucocytosis has also been reported previously)13,17,52,59.

In our previous study we had only two dogs infected solely with D. repens, and these presented with all blood indices within the normal range48. However, in the present study we analysed the blood parameters of 12 dogs infected only with D. repens and this time we found some alterations (decreased haemoglobin and glucose concentration, decreased haematocrit and MCHC), although these were limited in number. Interestingly, in another recent study comparing blood parameters of 197 D. repens-infected with those of 218 uninfected dogs from Poland39, no major alterations were found in infected dogs. However, as in our study, several modest but nevertheless significant differences were detected: lower mean RBC, lymphocyte and thrombocyte counts, decreased haematocrit and increased activity of ALP and creatinine were found in D. repens-infected dogs compared to uninfected dogs. In their further analysis of a subset of 214 dogs with haematological and biochemical results within normal reference ranges (93 D. repens- infected and 121 uninfected), lower numbers/values of lymphocytes, RBC and haematocrit, higher glucose concentration and borderline elevated ALP activity were observed in infected dogs compared to uninfected animals39. The authors concluded that despite D. repens infections being categorized as asymptomatic, some haematological and biochemical changes are associated with D. repens infections in dogs39. Haemoglobin levels and haematocrits below reference values were also found in our study (accompanied by decreased MCHC), and we also found slightly higher activity of all three liver enzymes in comparison to healthy dogs, but glucose concentration was decreased among our 12 D. repens-infected dogs. Thus, our study confirms also that unnoticed/unrecognized D. repens infection may have an impact on dog health.

Following the comparison of blood parameters, we identified and compared for the first time profiles of immune responses in dogs with single and double infections. Based on the literature61 and availability of TaqMan probes for dogs, we assessed the expression of selected Th1-related transcription factors/cytokines (IFN-γ, STAT4), Th2-related ones (IL-13, STAT6, SOCS3, GATA-3) and the T-regulatory IL-10 in four groups of dogs. In summary, we observed the expression of all tested transcription factors/cytokines, except INF-γ, in dogs infected only with D. repens. In dogs with mild/moderate babesiosis the expression of GATA3 was highest, while in dogs with advanced babesiosis the highest expression of INF-γ and SOCS3 was recorded. Expression of regulatory IL-10 was similar in both groups of Babesia-infected dogs. The expression of IL-13 was predominant in dogs infected with D. repens, and the expression of STAT6 and regulatory IL-10 predominated in dogs with co-infection. It appears then that a somewhat mixed expression of Th1-, T-regulatory and Th2-related transcription factors and cytokines was observed both in dogs infected with B. canis and co-infected with B. canis and D. repens. Although we expected a mixed Th1 and Th2 immune response in co-infected dogs, the mixed immune response in B. canis-infected dogs was not expected. Activation of STAT4, involved in controlling Th1 gene expression, induces production of IFN-γ62 and as we had predicted the highest expression of IFN-γ was indeed observed in dogs with advanced babesiosis (Babesia 2). The higher expression of STAT4 and IFN-γ is consistent with the hypothesis that in Babesia infections the immune response is skewed towards a Th1-profile. However, an important inhibitor of IL-12 mediated STAT4 activation is SOCS363 which was found to be expressed significantly higher in dogs with advanced babesiosis (Babesia 2 group). Although SOCS3 is expressed in both Th1 and Th2 cells, much higher expression has been reported in Th2 cells, and SOCS3 is known to inhibit IL-12-mediated activation of the STAT4 pathway, thereby inducing Th2 differentiation63,64. Also, STAT6, GATA3 and IL-10 expression was observed in B. canis-infected dogs, suggesting a switch of the immune response profile from Th1 to Th222,61. STAT6 inhibits the expression of IFN-γ, IL-12 and TNF-β and collaborates with GATA3, which promotes the expression of Th2 cytokines and suppresses the expression of IL-12 and STAT4 (inhibiting Th1 development)65,66. IL-10 is a cytokine with multiple effects on immunoregulation and inflammation and downregulates the expression of Th1 cytokines. Thus, the results of the current study do not indicate a clearly Th1-polarized profile in the course of canine babesiosis but rather a mixed expression of Th1-type and Th2-type transcription factors and cytokines. Interestingly, such a mixed profile of immune response (highest expression of either IFN-γ and SOCS3) was mostly observed in dogs with advanced babesiosis (Babesia 2), presenting with the most advanced alterations in blood counts and biochemistry, supporting the hypothesis of immune-mediated secondary pathology22. Furthermore, the expression of Th1 and Th2 cytokines/transcription factors in dogs with babesiosis was also accompanied by a relatively high and similar expression of regulatory IL-10. Interestingly, both uncomplicated and complicated babesiosis caused by Babesia rossi infection have been shown to induce pro‐inflammatory cytokine storms that correlate with disease severity and fatal outcomes. The authors investigated serum concentrations of 11 cytokines and generally, the more complicated the disease, the more pro‐inflammatory a cytokine profile was detected67. Moreover, the cytokine storm was associated with multiple organ damage during the course of B. rossi infection6769. Thus, features of mixed Th1/Th2 -related responses in dogs infected with B. canis may be associated with better clinical outcomes compared to the consequences of the Th1 proinflammatory activity in dogs with babesiosis attributed to B. rossi.

As in B. canis-infected dogs, the expression of all the tested cytokines/ transcription factors was detected in dogs co-infected with B. canis and D. repens. Again, a rather mixed expression of Th1-, T-regulatory and Th2-related cytokines/transcription factors was observed in these co-infected dogs. Both STAT6 and regulatory IL-10 displayed highest expression which may indicate a Th2/regulatory response and may correspond to lower levels of abnormalities in blood parameters in this group of dogs. In Beagle puppies experimentally infected with the less pathogenic Babesia gibsoni, IL-10 was detected only during the peak of parasitaemia and was followed by resolution of pyrexia and parasitaemia23. In co-infected dogs, the mixed profile of the immune response may be explained by a contribution of a filarial-induced Th2 response43,45. In contrast, in an experimental study on mice co-infected with filariae Litomosoides sigmodontis and Leishmania major, immune responses to L. major and L. sigmodontis were found to be highly compartmentalized and appropriately polarized, with a Th1 response to L. major in the popliteal lymphatic nodes (LNs) and a type 2 response to L. sigmodontis in the thoracic LNs45. Nevertheless, despite these contrasting immune responses in co-infected mice, the impact of filarial infection was still sufficient to delay footpad lesion progression. In an experimental study with Plasmodium berghei infected mice, exposed additionally to filarial infective larvae, cerebral malaria did not develop and their survival was significantly prolonged70.

In the group of D. repens-infected dogs, expression of IL-13 was relatively high, and accompanied by low expression of regulatory IL-10 (and lowest number of alterations in blood parameters). In pulmonary dirofilariasis due to D. immitis infection in dogs, the initial inflammatory reaction that occurs in the walls of the pulmonary vasculature is critical in the development of the entire disease process35. Similar to D. repens, in dogs infected with D. immitis both patent infection with circulating MFs and occult infection with no detectable MFs may occur35. Dogs with patent D. immitis infection had higher expression of circulating IL-4, IL-10 and induced nitric oxide synthase (iNOS) than dogs with occult infection40.

Data on the mRNA expression of the different cytokines have shown that both innate and acquired immune responses are present in D. immitis infected dogs35,40. Important proinflammatory mediators, as iNOs and tumour necrosis factor (TNF-α) were consistently present. The expression of Th1-and Th2-related interleukins (IL-2, IL-4, IL-5) has also been detected. Regulatory IL-10 was present in dogs with patent infections, while it was not expressed at detectable levels in amicrofilaraemic dogs. This cytokine has been implicated in the hyporesponsiveness observed in filarioses35.

Interestingly, it was demonstrated that Wolbachia, bacterial endosymbiont of Dirofilaria spp., interacts with D. immitis- infected hosts41. Wolbachia was identified in many organs/cells of D. immitis-infected dogs such as renal tubular cells, glomeruli or inflammatory pulmonary cells by the use of immunohistochemistry techniques employing a polyclonal antibody against the Wolbachia surface protein (WSP)41,71. Moreover, IgG antibodies against WSP have been detected in cats with D. immitis infections, in humans diagnosed with pulmonary dirofilariosis, and in healthy, seropositive humans living in areas endemic for heartworm35. High titres of specific IgG antibodies have also been detected in dogs with different clinical presentations of pulmonary dirofilariosis41. For example, in an amicrofilaraemic dog with massive pulmonary thromboembolism, the IgG response to both Wolbachia and D. immitis antigens was much higher than in other amicrofilaraemic dogs that were asymptomatic35. These findings suggest the extremely complex immune response in dogs infected with Dirofilaria spp.

Our study has several limitations. Molecular methods did not allow for detection of the D. repens infection in amicrofilaraemic dogs. The study on immune responses is based solely on mRNA detection, and next needs to be further expanded by detection of cytokine/transcription factors and proteins in the sera of dogs with single and double infections. Collection of serum was not possible in the present study (only EDTA-fixed blood samples were available). Furthermore, a selected range of cytokines/transcription factors was used, mainly due to limitation in accessibility of probes and of financial support. Assessment of the degree of expression of other key cytokines/factors such as IL-2, IL-12, TNF-α and TNF-β or SOCS5 could help to more accurately define the immune response profile. For example, in the study by Zygner et al. (2014)72 an increase of serum TNF-α concentration was observed during canine babesiosis, and this increased TNF-α concentration affected the development of hypotension and renal failure in canine babesiosis due to B. canis.

Conclusions

In summary, with just a few mild exceptions, no major alterations were found in blood parameters of dogs infected only with D. repens, and these dogs predominantly expressed Th2-related cytokines/factors. Dogs infected with B. canis showed mixed expression of immune response cytokines/transcription factors and showed marked pathology. While some features of Th1, T-regulatory and Th2 responses were observed in B. canis and D. repens co-infected dogs, the Th2-related response appeared to predominate in these animals, and values of biochemical parameters were closer to those of healthy dogs than those solely infected with B. canis, suggesting a milder course of babesiosis in these animals. These findings are important due to the current spread of dirofilariosis and babesiosis in central Europe.

Acknowledgements

The study was funded by the National Science Centre (NCN) OPUS grant no. 2017/27/B/NZ6/01691.

Author contributions

A.B., D.W. and K.R. conceived, designed, and conducted the study, analyzed the data, and wrote the paper. D.K. conducted the study and statistical analyses. A.R. contributed to acquisition of data, analyzed the data and revised the paper. All authors read and approved the final manuscript.

Funding

The study was funded by the National Science Centre (NCN) OPUS grant no. 2017/27/B/NZ6/01691.

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author (AB) on reasonable request.

Competing interests:

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Dagmara Wężyk and Karolina Romanczuk.

References

  • 1.Bajer A, Kowalec M, Levytska VA, Mierzejewska EJ, Alsarraf M, Poliukhovych V, Rodo A, Wężyk D, Dwużnik-Szarek D. Tick-borne pathogens, Babesia spp. and Borrelia burgdorferi s.l., in sled and companion dogs from central and north-eastern Europe. Pathogens. 2022;11:499. doi: 10.3390/pathogens11050499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dwużnik-Szarek D, Mierzejewska EJ, Rodo A, Goździk K, Behnke-Borowczyk J, Kiewa D, Kartawik N, Bajer A. Monitoring the expansion of Dermacentor reticulatus and occurrence of canine babesiosis in Poland in 2016–2018. Parasit. Vectors. 2021;14:1–18. doi: 10.1186/s13071-021-04758-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fuehrer HP, Morelli S, Unterköfler MS, Bajer A, Bakran-Lebl K, Dwużnik-Szarek D, Farkas R, Grandi G, Heddergott M, Jokelainen P, Knific T, Leschnik M, Miterpáková M, Modrý D, Petersen HH, Skírnisson K, VerglesRataj A, Schnyder M, Strube C. Dirofilaria spp. and Angiostrongylus vasorum: Current risk of spreading in central and northern Europe. Pathogens. 2021;10:1268. doi: 10.3390/pathogens10101268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Alsarraf M, Levytska V, Mierzejewska EJ, Poliukhovych V, Rodo A, Alsarraf M, Kavalevich D, Dwużnik-Szarek D, Behnke JM, Bajer A. Emerging risk of Dirofilaria spp. infection in Northeastern Europe: High prevalence of Dirofilaria repens in sled dog kennels from the Baltic countries. Sci. Rep. 2021;11:1–8. doi: 10.1038/s41598-020-80208-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Genchi C, Mortarino M, Rinaldi L, Cringoli G, Traldi G, Genchi M. Changing climate and changing vector-borne disease distribution: The example of Dirofilaria in Europe. Vet. Parasitol. 2011;176:295–299. doi: 10.1016/j.vetpar.2011.01.012. [DOI] [PubMed] [Google Scholar]
  • 6.Capelli G, Genchi C, Baneth G, Bourdeau P, Brianti E, Cardoso L, Danesi P, Fuehrer HP, Giannelli A, Ionica A, Maia C, Modry D, Montarsi F, Krucken J, Papadopoulos E, Petric D, Pfeffer M, Savic S, Otranto D, Poppert S, Silaghi C. Recent advances on Dirofilaria repens in dogs and humans in Europe. Parasit. Vectors. 2018;11:663. doi: 10.1186/s13071-018-3205-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Genchi C, Kramer LH. The prevalence of Dirofilaria immitis and D. repens in the Old World. Vet. Parasitol. 2020;280:108995. doi: 10.1016/j.vetpar.2019.108995. [DOI] [PubMed] [Google Scholar]
  • 8.Simón F, Siles-Lucas M, Morchon R, Gonzales-Miguel J, Mellado I, Carreton E, Montoya-Alonso J. Human and animal dirofilariasis: The emergence of a zoonotic mosaic. Clin. Microbiol. Rev. 2012;25:507–544. doi: 10.1128/CMR.00012-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Simón F, Gonzalez-Miguel J, Diosdado A, Gomez PJ, Morchon R, Kartashev V. The complexity of zoonotic filariasis episystem and its consequences: A multidisciplinary view. Biomed. Res. Int. 2017;2017:6436130. doi: 10.1155/2017/6436130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bajer A, Beck A, Beck R, Behnke JM, Dwużnik-Szarek D, Eichenberger RM, Farkas R, Fuehrer H-P, Heddergott M, Jokelainen P, Leschnik M, Oborina V, Paulauskas A, Radzijevskaja J, Ranka R, Schnyder M, Springer A, Strube C, Tolkacz K, Walochnik J. Babesiosis in Southeastern, Central and Northeastern Europe: An emerging and re-emerging tick-borne disease of humans and animals. Microorganisms. 2022;10:945. doi: 10.3390/microorganisms10050945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Solano-Gallego L, Sainz Á, Roura X, Estrada-Peña A, Miró G. A review of canine babesiosis: The European perspective. Parasit. Vectors. 2016;9:1–18. doi: 10.1186/s13071-016-1596-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Matijatko V, Torti M, Schetters TP. Canine babesiosis in Europe: How many diseases? Trends Parasitol. 2012;28:99–105. doi: 10.1016/j.pt.2011.11.003. [DOI] [PubMed] [Google Scholar]
  • 13.Adaszek Ł, Winiarczyk S, Skrzypczak M. The clinical course of babesiosis in 76 dogs infected with protozoan parasites Babesia canis canis. Pol. J. Vet. Sci. 2009;12:81–87. [PubMed] [Google Scholar]
  • 14.Welc-Falęciak R, Rodo A, Siński E, Bajer A. Babesia canis and other tick-borne infections in dogs in Central Poland. Vet. Parasitol. 2009;166:191–198. doi: 10.1016/j.vetpar.2009.09.038. [DOI] [PubMed] [Google Scholar]
  • 15.Freeman MJ, Kirby BM, Panciera DL, Henik RA, Rosin E, Sullivan LJ. Hypotensive shock syndrome associated with acute Babesia canis infection in a dog. J. Am. Vet. Med. Assoc. 1994;204:94–96. [PubMed] [Google Scholar]
  • 16.Bourdoiseau G. Canine babesiosis in France. Vet. Parasitol. 2006;138:118–125. doi: 10.1016/j.vetpar.2006.01.046. [DOI] [PubMed] [Google Scholar]
  • 17.Zygner W, Gójska O, Rapacka G, Jaros D, Wędrychowicz H. Hematological changes during the course of canine babesiosis caused by large Babesia in domestic dogs in Warsaw (Poland) Vet. Parasitol. 2007;145:146–151. doi: 10.1016/j.vetpar.2006.11.008. [DOI] [PubMed] [Google Scholar]
  • 18.Zygner W, Rodo A, Gójska-Zygner O, Górski P, Bartosik J, Kotomski G. Disorders in blood circulation as a probable cause of death in dogs infected with Babesia canis. J. Vet. Res. 2021;65:277–285. doi: 10.2478/jvetres-2021-0036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bloch EM, Kumar S, Krause PJ. Persistence of Babesia microti infection in humans. Pathogens. 2019;17:102. doi: 10.3390/pathogens8030102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Welc-Falęciak R, Bajer A, Bednarska M, Paziewska A, Siński E. Long term monitoring of Babesia microti infection in BALB-c mice using nested PCR. Ann. Agric. Environ. Med. 2007;14:258. [PubMed] [Google Scholar]
  • 21.Tołkacz K, Rodo A, Wdowiarska A, Bajer A, Bednarska M. Impact of Babesia microti infection on the initiation and course of pregnancy in BALB/c mice. Parasit. Vectors. 2021;14:1–17. doi: 10.1186/s13071-021-04638-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Day MJ. The immunopathology of canine vector-borne diseases. Parasit. Vectors. 2011;4:48. doi: 10.1186/1756-3305-4-48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Brown AL, Shiel RE, Irwin PJ. Clinical, haematological, cytokine and acute phase protein changes during experimental Babesia gibsoni infection of Beagle puppies. Exp. Parasitol. 2015;157:185–196. doi: 10.1016/j.exppara.2015.08.002. [DOI] [PubMed] [Google Scholar]
  • 24.Schetters T, Kleuskens J, Van De Crommert J, De Leeuw D, Finizio A, Gorenflot A. Systemic inflammatory responses in dogs experimentally infected with Babesia canis; a haematological study. Vet. Parasitol. 2009;162:7–15. doi: 10.1016/j.vetpar.2009.02.012. [DOI] [PubMed] [Google Scholar]
  • 25.Igarashi I, Suzuki R, Waki S, Tagawa Y, Seng S, Tum S, Omata Y, Saito A, Nagasawa H, Iwakura Y, Suzuki N, Mikami T, Toyoda Y. Roles of CD41 T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infect. Immun. 1999;67:143–148. doi: 10.1128/iai.67.8.4143-4148.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Homer MJ, Aguilar-Delfi I, Telford SR, Krause PJ, Persing DH. Babesiosis. Clin. Microbiol. Rev. 2000;13:451–469. doi: 10.1128/cmr.13.3.451-469.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tarello W. Clinical aspects of dermatitis associated with Dirofilaria repens in pets: A review of 100 canine and 31 feline cases (1990–2010) and a report of a new clinic case imported from Italy to Dubai. J. Parasitol. Res. 2011;2011:214–220. doi: 10.1155/2011/578385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Simón F, Morchón R, González-Miguel J, Marcos-Atxutegi C, Siles-Lucas M. What is new about animal and human dirofilariosis? Trends Parasitol. 2009;25:404–409. doi: 10.1016/j.pt.2009.06.003. [DOI] [PubMed] [Google Scholar]
  • 29.Bajer A, Mierzejewska EJ, Rodo A, Bednarska M, Kowalec M, Welc-Falęciak R. The risk of vector-borne infections in sled dogs associated with existing and new endemic areas in Poland: Part 1: A population study on sled dogs during the racing season. Vet. Parasitol. 2014;202:276–286. doi: 10.1016/j.vetpar.2013.12.033. [DOI] [PubMed] [Google Scholar]
  • 30.Tahir D, Bittar F, Barré-Cardi H, Sow D, Dahmani M, Mediannikov O, Didier R, Davoust B, Parola P. Molecular survey of Dirofilaria immitis and Dirofilaria repens by new real-time TaqMan®PCR assay in dogs and mosquitoes (Diptera: Culicidae) in Corsica (France) Vet. Parasitol. 2017;235:1–7. doi: 10.1016/j.vetpar.2017.01.002. [DOI] [PubMed] [Google Scholar]
  • 31.Bocková E, Iglódyová A, Kočišová A. Potential mosquito (Diptera:Culicidae) vector of Dirofilaria repens and Dirofilaria immitis in urban areas of Eastern Slovakia. J. Parasitol. Res. 2015;114:4487–4492. doi: 10.1007/s00436-015-4692-8. [DOI] [PubMed] [Google Scholar]
  • 32.Vezzani D, Carbajo A. Spatial and temporal transmission risk of Dirofilaria immitis in Argentina. Int. J. Parasitol. 2006;36:1463–1472. doi: 10.1016/j.ijpara.2006.08.012. [DOI] [PubMed] [Google Scholar]
  • 33.Webber W, Hawking F. Experimental maintenance of Dirofilaria repens and D. immitis in dogs. Exp. Parasitol. 1955;4:143–164. doi: 10.1016/0014-4894(55)90007-2. [DOI] [PubMed] [Google Scholar]
  • 34.Vismarra, A., Genchi, M., Cattabiani, C., & Kramer, L. Dirofilaria spp. Do They Get Under Your Skin (Or into Your Heart)? Dog Parasites Endangering Human Health. 227–237 (Springer, 2020).
  • 35.Simón F, Kramer LH, Román A, Blasini W, Morchon R, Marcos-Atxutegi C, Grandi G, Genchi C. Immunopathology of Dirofilaria immitis infection. Vet. Res. Commun. 2007;3:161–171. doi: 10.1007/s11259-006-3387-0. [DOI] [PubMed] [Google Scholar]
  • 36.Osińska B, Demiaszkiewicz AW, Pyziel AM, Dolka I. Prevalence of Dirofilaria repens in dogs in central-eastern Poland and histopathological changes caused by this infection. J. Vet. Res. 2014;58:35–39. [Google Scholar]
  • 37.Demiaszkiewicz AW, Polanczyk G, Osinska B, Pyziel AM, Kuligowska I, Lachowicz J. Morphometric characteristics of Dirofilaria repens Railliet et Henry, 1911 parasite of dogs in Poland. Wiad Parazytol. 2011;57:253–256. [Google Scholar]
  • 38.Di Cesare A, Otranto D, Di Giulio E, Simonato G, Latrofa M, La Torre F, Coccia G, Traversa D. Microfilarial periodicity of Dirofilaria repens in naturally infested dogs. Parasitol. Res. 2013;112:4273–4279. doi: 10.1007/s00436-013-3619-5. [DOI] [PubMed] [Google Scholar]
  • 39.Wysmołek ME, Dobrzyński A, Długosz E, Czopowicz M, Wiśniewski M, Jurka P, Klockiewicz M. Hematological and biochemical changes in dogs naturally infected with Dirofilaria repens. Front. Vet. Sci. 2020;7:590. doi: 10.3389/fvets.2020.00590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Morchon R, López-Belmonte J, Bazzocchi C, Grandi G, Kramer L, Simón F. Dogs with patent Dirofilaria immitis infection have higher expression of circulating IL-4, IL-10 and iNOS mRNA than those with occult infection. Vet. Immunol. Immunopathol. 2007;115:184–188. doi: 10.1016/j.vetimm.2006.10.004. [DOI] [PubMed] [Google Scholar]
  • 41.Kramer LH, Tamarozzi F, Morchon R, Lopez-Belmonte J, Marcos-Atxutegi C, Martin-Pacho R, Simon F. Immune response to and tissue localization of the Wolbachia surface protein (WSP) in dogs with natural heartworm (Dirofilaria immitis) infection. Vet. Immunol. Immunopathol. 2005;106:303–308. doi: 10.1016/j.vetimm.2005.03.011. [DOI] [PubMed] [Google Scholar]
  • 42.Behnke JM. Evasion of immunity by nematode parasites causing chronic infections. Adv. Parasitol. 1987;26:1–71. doi: 10.1016/s0065-308x(08)60294-8. [DOI] [PubMed] [Google Scholar]
  • 43.Behnke JM, Barnard CJ, Wakelin D. Understanding chronic nematode infections: Evolutionary considerations, current hypotheses and the way forward. Int. J. Parasitol. 1992;22:861–907. doi: 10.1016/0020-7519(92)90046-n. [DOI] [PubMed] [Google Scholar]
  • 44.Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: Cellular and molecular mechanisms. Nat. Rev. Immunol. 2003;3:733–744. doi: 10.1038/nri1183. [DOI] [PubMed] [Google Scholar]
  • 45.Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. Helminth parasites—Masters of regulation. Immunol. Rev. 2004;201:89–116. doi: 10.1111/j.0105-2896.2004.00191.x. [DOI] [PubMed] [Google Scholar]
  • 46.Maizels RM, Smits HH, McSorley HJ. Modulation of host immunity by helminths: The expanding repertoire of parasite effector molecules. Immunity. 2018;49:801–818. doi: 10.1016/j.immuni.2018.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Nacher M. Worms and malaria: Blind men feeling the elephant? Parasitology. 2008;135:861–868. doi: 10.1017/S0031182008000358. [DOI] [PubMed] [Google Scholar]
  • 48.Bajer A, Rodo A, Mierzejewska EJ, Tołkacz K, Welc-Faleciak R. The prevalence of Dirofilaria repens in cats, healthy dogs and dogs with concurrent babesiosis in an expansion zone in central Europe. BMC Vet. Res. 2016;12:1–10. doi: 10.1186/s12917-016-0816-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Bonnet S, Jouglin M, L’Hotis M, Chauvin A. Babesia sp. EU1 from roe deer and transmission within Ixodes ricinus. Emerg. Infect. Dis. 2007;13:1208–1210. doi: 10.3201/eid1308.061560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Mierzejewska EJ, Estrada-Peña A, Alsarraf M, Kowalec M, Bajer A. Mapping of Dermacentor reticulatus expansion in Poland in 2012–2014. Ticks Tick Borne Dis. 2016;7:94–106. doi: 10.1016/j.ttbdis.2015.09.003. [DOI] [PubMed] [Google Scholar]
  • 51.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 52.Zygner W, Gójska-Zygner O, Długosz E, Wędrychowicz H. Liver enzyme activity in dogs infected with Babesia canis. Bull Vet Inst. Puławy. 2011;55:423–427. [Google Scholar]
  • 53.Taboada, J., & Lobetti, R. Babesiosis. in Infectious Diseases of the Dog and Cat (Greene, C. E. ed.). 3rd edn. 722–736. (WB Saunders, 2006).
  • 54.Giannini EG, Testa R, Savarino V. Liver enzyme alteration—A guide for clinicians. CMAJ. 2005;172:367–379. doi: 10.1503/cmaj.1040752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wadhwa DR, Pal B, Mandial RK, Kumar A, Agnihotri RK. Clinical, haemato-biochemical and therapeutic studies of canine babesiosis in Kangra valley of Himachal Pradesh. J. Vet. Parasitol. 2011;25:39–41. [Google Scholar]
  • 56.Crnogaj M, Petlevski R, Mrljak V, Kis I, Torti M, Kucer N, Matijatko V, Sacer I, Stokovic I. Malondialdehyde levels in serum of dogs infected with Babesia canis. Vet. Med. 2010;55:163–171. [Google Scholar]
  • 57.Bilwal A, Mandali G, Tandel F. Liver enzyme activity in dogs infected with Babesia canis. Intas Polivet. 2018;19:313–314. [Google Scholar]
  • 58.Zygner W, Gójska-Zygner O, Wesołowska A, Wędrychowicz H. Urinary creatinine to serum creatinine ratio and renal failure index in dogs infected with Babesia canis. Acta Parasitol. 2013;58:297–303. doi: 10.2478/s11686-013-0145-7. [DOI] [PubMed] [Google Scholar]
  • 59.Furlanello T, Fiorio F, Caldin M, Lubas G, Solano-Gallego L. Clinicopathological findings in naturally occurring cases of babesiosis caused by large form Babesia from dogs of northeastern Italy. Vet. Parasitol. 2005;134:77–85. doi: 10.1016/j.vetpar.2005.07.016. [DOI] [PubMed] [Google Scholar]
  • 60.Zygner W, Gójska-Zygner O, Bąska P, Długosz E. Increased concentration of serum TNF alpha and its correlations with arterial blood pressure and indices of renal damage in dogs infected with Babesia canis. Parasitol. Res. 2014;113:1499–1503. doi: 10.1007/s00436-014-3792-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Schlotter M, Rutten P, Riemers M, Knol F, Willemse T. Lesional skin in atopic dogs shows a mixed type-1 and type-2 immune responsiveness. Vet. Immunol. Immunopathol. 2011;143:20–26. doi: 10.1016/j.vetimm.2011.05.025. [DOI] [PubMed] [Google Scholar]
  • 62.Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O’Shea JJ. Signalling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 2004;202:139–156. doi: 10.1111/j.0105-2896.2004.00211.x. [DOI] [PubMed] [Google Scholar]
  • 63.Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, Komine O, Hamano S, Himeno K, Inagaki-Ohara K, Cacalano N, O’Garra A, Oshida T, Saito H, Johnston J, Yoshimura A, Kubo M. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat. Med. 2003;9:1047–1054. doi: 10.1038/nm896. [DOI] [PubMed] [Google Scholar]
  • 64.Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 2007;7:454–465. doi: 10.1038/nri2093. [DOI] [PubMed] [Google Scholar]
  • 65.Mowen KA, Glimcher LH. Signalling pathways in Th2 development. Immunol. Rev. 2004;202:203–222. doi: 10.1111/j.0105-2896.2004.00209.x. [DOI] [PubMed] [Google Scholar]
  • 66.Ho IC, Tai TS, Pai SY. GATA3 and the T-cell lineage: Essential functions before and after T-helper-2-cell differentiation. Nat. Rev. Immunol. 2009;9:125–135. doi: 10.1038/nri2476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Leisewitz A, Goddard A, De Gier J, Van Engelshoven J, Clift S, Thompson P, Schoeman J. Disease severity and blood cytokine concentrations in dogs with natural Babesia rossi infection. Parasite Immunol. 2019;41:126–130. doi: 10.1111/pim.12630. [DOI] [PubMed] [Google Scholar]
  • 68.Jacobson LS. The South African form of severe and complicated Canine babesiosis: Clinical advances 1994–2004. Vet. Parasitol. 2006;138:126–139. doi: 10.1016/j.vetpar.2006.01.047. [DOI] [PubMed] [Google Scholar]
  • 69.Welzl C, Leisewitz AL, Jacobson LS, Vaughan-Scott T, Myburgh E. Systemic inflammatory response syndrome and multiple-organ damage/dysfunction in complicated canine babesiosis. J. S. Afr. Vet. Assoc. 2001;72:158–162. doi: 10.4102/jsava.v72i3.640. [DOI] [PubMed] [Google Scholar]
  • 70.Yan Y, Inuo G, Akao N, Tsukidate S, Fujita K. Down-regulation of murine susceptibility to cerebral malaria by inoculation with third stage larvae of the filarial nematode Brugia pahangi. Parasitology. 1997;114:333–338. doi: 10.1017/s0031182096008566. [DOI] [PubMed] [Google Scholar]
  • 71.Kramer L, Passeri B, Corona S, Simoncini L, Casiraghi M. Immunohistochemical/immunogold detection and distribution of the endosymbiont Wolbachia of Dirofilaria immitis and Brugia pahangi using a polyclonal antiserum raised against WSP (Wolbachia surface protein) Parasitol. Res. 2003;89:381–386. doi: 10.1007/s00436-002-0765-6. [DOI] [PubMed] [Google Scholar]
  • 72.Zygner W, Gójska-Zygner O. Increased serum urea to creatinine ratio and its negative correlation with arterial pressure in canine babesiosis. Acta Parasitol. 2014;59:548–551. doi: 10.2478/s11686-014-0273-8. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author (AB) on reasonable request.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES